Company’s proprietary peptide platform expands beyond agriculture into human recovery, performance, and wellnessWoodland, CA, March 04, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health, today announced its formal entry into the human health and wellness sector, marking a significant expansion of its corporate strategy into consumer-focused biological innovation. Th ...